Merck (MRK) EBITDA (2009 - 2026)
Merck's EBITDA came in at $999 million for Q2 2026, down 83.7% from $6.11 billion a year earlier.
Powered by 
Analysis
Merck (MRK) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Merck reported EBITDA of $13.09 billion, down 44.7% year-over-year; for FY2025, it was $27.06 billion, up 10.8% from FY2024.
- EBITDA carries a five-year compound annual growth rate of 26.1% (FY2020 to FY2025).
- Going back by year, EBITDA was $24.41 billion in FY2024 (-33.6%), $36.76 billion in FY2023 (+68.2%), $21.85 billion in FY2022 (+38.5%) and $15.77 billion in FY2021 (+85.8%).
- The five-year range for quarterly EBITDA is -$4.26 billion (Q2 2023) to $7.66 billion (Q3 2025).
- Year-over-year, EBITDA increased in four of the last seven quarters, with growth averaging 3.3%.
- The fastest year-over-year change in EBITDA over five years came in Q2 2022 (growth of 150.3%), and the weakest in Q2 2026 (a decline of 83.7%).
- Business Quant data shows MRK's EBITDA at -$1.88 billion (Q1 2026), $6.32 billion (Q4 2025) and $7.66 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 782.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.34 Bn |
| Jun 30, 2026 | 900.00 Mn |
| Mar 31, 2026 | -2.02 Bn |
| Dec 31, 2025 | 5.89 Bn |
| Sep 30, 2025 | 7.90 Bn |
| Jun 30, 2025 | 6.12 Bn |
| Mar 31, 2025 | 7.00 Bn |
| Dec 31, 2024 | 5.37 Bn |
| Sep 30, 2024 | 5.28 Bn |
| Jun 30, 2024 | 7.14 Bn |
| Mar 31, 2024 | 6.65 Bn |
| Dec 31, 2023 | -1.08 Bn |
| Sep 30, 2023 | 6.63 Bn |
| Jun 30, 2023 | -4.43 Bn |
| Mar 31, 2023 | 4.64 Bn |
| Dec 31, 2022 | 4.41 Bn |
| Sep 30, 2022 | 4.54 Bn |
| Jun 30, 2022 | 5.43 Bn |
| Mar 31, 2022 | 5.98 Bn |
| Dec 31, 2021 | 4.77 Bn |
API Access
Merck EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();